Cargando…

Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity in individuals with obesity. Although multiple pharmacotherapeutics are in development, currently there are limited strategies specifically targeting NAFLD. This systematic review summarizes the existing literature on hepatic effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Chelsea S., Stanley, Takara L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046622/ https://www.ncbi.nlm.nih.gov/pubmed/32153507 http://dx.doi.org/10.3389/fendo.2020.00070

Ejemplares similares

Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis
por: Li, Xiaoya, et al.
Publicado: (2022)

Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis
por: Zhou, Peipei, et al.
Publicado: (2023)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line
por: Yehezkel, Adi S., et al.
Publicado: (2023)

Steatosis and Steatohepatitis: Complex Disorders
por: Bettermann, Kira, et al.
Publicado: (2014)

Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice
por: Lombardo, Giovanni Enrico, et al.
Publicado: (2018)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Cardiovascular Risks and Benefits of Medications Used for Weight Loss
por: Bramante, Carolyn T., et al.
Publicado: (2020)

Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk
por: Pasmans, Kenneth, et al.
Publicado: (2021)

Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
por: Chang, Jae Seung, et al.
Publicado: (2022)

Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020
por: Shen, Yun, et al.
Publicado: (2023)

SAT-256 Obesity and Reactive Airway Disease Are Increased Among HIV-Exposed Uninfected Adolescents
por: Fourman, Lindsay, et al.
Publicado: (2019)

OR24-06 The Role Of Oxidative Stress In The Association Of Smoking And Alcohol Consumption With Hepatic Steatosis
por: Shaheen, Magda, et al.
Publicado: (2023)

Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome
por: Pascut, Devis, et al.
Publicado: (2023)

Key hepatic signatures of human and mouse nonalcoholic steatohepatitis: A transcriptome–proteome data meta-analysis
por: Pyo, Jeong Joo, et al.
Publicado: (2022)

OR15-06 Measuring Hepatic Steatosis With Transient Elastography In Adolescents With Obesity
por: Sundararajan, Divya, et al.
Publicado: (2023)

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
por: Cataldi, Mauro, et al.
Publicado: (2021)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
por: Hwang, Seonghwan, et al.
Publicado: (2021)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Evolution of Hepatic Steatosis to Fibrosis and Adenoma Formation in Liver-Specific Growth Hormone Receptor Knockout Mice
por: Fan, Yong, et al.
Publicado: (2014)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density
por: Xie, Ruijie, et al.
Publicado: (2022)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
por: Semmler, Georg, et al.
Publicado: (2023)

Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus)
por: Ventura, Luciana L.A., et al.
Publicado: (2017)

Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
por: Starmann, Julia, et al.
Publicado: (2012)

Interventions associated with brown adipose tissue activation and the impact on energy expenditure and weight loss: A systematic review
por: Perez, Luis C., et al.
Publicado: (2022)

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Fang, et al.
Publicado: (2020)

Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2021)

Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway
por: Feng, Xu, et al.
Publicado: (2022)

Association of family income to poverty ratio and vibration-controlled transient elastography quantified degree of hepatic steatosis in U.S. adolescents
por: Tang, Meiling, et al.
Publicado: (2023)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
por: Zhang, Zhiguo, et al.
Publicado: (2016)

Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
por: Català-Senent, José F., et al.
Publicado: (2021)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
por: Kim, Kook Hwan, et al.
Publicado: (2018)

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
por: Ferolla, Silvia M., et al.
Publicado: (2016)

Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
por: Rausch, Linda K., et al.
Publicado: (2018)

OR24-05 High Waist Circumference Is Strongly Predictive Of Hepatic Steatosis And Significant Fibrosis
por: Janakiram, Nikhila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l4ktb2paeaphh9944oia54021j